Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,710 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,126
Recruiting: 10,896
Ph III recruiting: 1,279
Growth YoY: +12.3%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,169)

clinicaltrialsPublishedShowing 651–700 of 4,691 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06253871	A Phase 1/1b Study of IAM1363 in HER2 Cancers	recruiting	Phase 1	383	Iambic Therapeutics, IncINDUSTRY	8	Sep 9, 2026	clinicaltrials
NCT06410248	Triapine in Combination With Temozolomide for the Treatment of Patients With Recurrent Glioblastoma	recruiting	Phase 1	22	Northwestern UniversityOTHER	1	Sep 9, 2026	clinicaltrials
NCT06440005